Free Trial
→ Your Bank Account Is No Longer Safe (From Priority Gold) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
KNCT
Invesco Next Gen Connectivity ETF
$115.86
+0.1%		$111.72
$86.24
▼
$120.24
$33.60M0.95997 shs605 shs
KSTR
KraneShares SSE Star Market 50 Index ETF
$13.68
-0.2%		$13.55
$9.26
▼
$21.00
$26.68M0.6342,652 shs4,602 shs
MARB
First Trust Merger Arbitrage ETF
$20.35
-1.0%		$20.30
$19.12
▼
$22.33
$33.57M0.0712,352 shs3,679 shs
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
$26.10
+1.0%		$25.25
$20.01
▼
$29.21
$34.45MN/A12,443 shs7,829 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover
Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
KNCT
Invesco Next Gen Connectivity ETF
-0.03%-1.38%+4.15%+20.94%+12.13%
KSTR
KraneShares SSE Star Market 50 Index ETF
+0.51%+0.96%+2.70%+1.63%+37.69%
MARB
First Trust Merger Arbitrage ETF
-0.19%+0.34%+1.58%+3.37%+3.94%
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
-1.22%+1.06%-4.75%+17.45%-9.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
KNCT
Invesco Next Gen Connectivity ETF
N/AN/AN/AN/AN/AN/AN/AN/A
KSTR
KraneShares SSE Star Market 50 Index ETF
N/AN/AN/AN/AN/AN/AN/AN/A
MARB
First Trust Merger Arbitrage ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
KNCT
Invesco Next Gen Connectivity ETF
2.70
Moderate Buy$115.86N/A
KSTR
KraneShares SSE Star Market 50 Index ETF
0.00
N/AN/AN/A
MARB
First Trust Merger Arbitrage ETF
2.14
Hold$20.35N/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
2.65
Moderate Buy$26.10N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
KNCT
Invesco Next Gen Connectivity ETF
N/AN/AN/AN/AN/AN/A
KSTR
KraneShares SSE Star Market 50 Index ETF
N/AN/AN/AN/AN/AN/A
MARB
First Trust Merger Arbitrage ETF
N/AN/AN/AN/AN/AN/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
KNCT
Invesco Next Gen Connectivity ETF
N/AN/A24.46∞N/AN/AN/AN/AN/A
KSTR
KraneShares SSE Star Market 50 Index ETF
N/AN/A0.00∞N/AN/AN/AN/AN/A
MARB
First Trust Merger Arbitrage ETF
N/AN/A20.69∞N/AN/AN/AN/AN/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
N/AN/A22.34∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
KNCT
Invesco Next Gen Connectivity ETF
$1.291.11%N/AN/AN/A
KSTR
KraneShares SSE Star Market 50 Index ETF
N/AN/AN/AN/AN/A
MARB
First Trust Merger Arbitrage ETF
$0.351.72%N/AN/AN/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
$0.050.19%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
KNCT
Invesco Next Gen Connectivity ETF
N/A
KSTR
KraneShares SSE Star Market 50 Index ETF
N/A
MARB
First Trust Merger Arbitrage ETF
N/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
N/A

Insider Ownership

CompanyInsider Ownership
KNCT
Invesco Next Gen Connectivity ETF
N/A
KSTR
KraneShares SSE Star Market 50 Index ETF
30.10%
MARB
First Trust Merger Arbitrage ETF
N/A
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
KNCT
Invesco Next Gen Connectivity ETF
N/A290,000N/ANot Optionable
KSTR
KraneShares SSE Star Market 50 Index ETF
N/A1.95 millionN/ANot Optionable
MARB
First Trust Merger Arbitrage ETF
N/A1.65 millionN/ANot Optionable
Roundhill GLP-1 & Weight Loss ETF stock logo
OZEM
Roundhill GLP-1 & Weight Loss ETF
N/A1.32 millionN/AN/A

Recent News About These Companies

How to avoid nausea on Ozempic and GLP-1 medications
March 17, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/10-expert-approved-tips-to-avoid-nausea-on-ozempic-and-glp-1-medications/ar-AA1B65Se
Scientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less Nausea
March 16, 2025  |  gizmodo.comG
Employers face pressure to add coverage of Ozempic, other weight-loss drugs
March 12, 2025  |  bizjournals.comhttps://www.bizjournals.com/orlando/news/2025/03/12/ozempic-wegovy-zepbound-health-insurance.html
Here’s why Ozempic maker’s new weight-loss drug isn’t good enough for investors
March 10, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/here-s-why-ozempic-maker-s-new-weight-loss-drug-isn-t-good-enough-for-investors/ar-AA1AC4vD
Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects
March 7, 2025  |  msn.comhttps://www.msn.com/en-gb/health/other/naturally-occurring-molecule-suppresses-appetite-and-promotes-weight-loss/ar-AA1AlJLS
More yogurt and nuts, less alcohol and snack foods: How GLP-1 medications like Ozempic are influencing people’s food spending habits
March 5, 2025  |  yahoo.comhttps://www.yahoo.com/lifestyle/more-yogurt-and-nuts-less-alcohol-and-snack-foods-how-glp-1-medications-like-ozempic-are-influencing-peoples-food-spending-habits-100059577.html
5 Sector ETFs Up 10% Despite February's Market Slump
March 3, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2424461/5-sector-etfs-up-10-despite-february-s-market-slump?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2424461
Drug compounders sue over weight loss drugs’ removal from FDA shortage list
February 25, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/drug-compounders-sue-over-weight-loss-drugs-removal-from-fda-shortage-list/ar-AA1zMw1h
How experiments with gila monster venom led to blockbuster weight loss drugs like Ozempic
February 24, 2025  |  whyy.orgW
Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.
February 23, 2025  |  washingtonpost.comhttps://www.washingtonpost.com/health/2025/02/23/ozempic-wegovy-change-life-spending/
FDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizes
February 21, 2025  |  seekingalpha.comhttps://seekingalpha.com/news/4412026-fda-to-spare-ozempic-compounders-shortage-ends
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
February 21, 2025  |  msn.comhttps://www.msn.com/en-us/health/diseases-and-conditions/yearslong-shortage-of-popular-weight-loss-and-diabetes-drugs-is-resolved-fda-says/ar-AA1zx4rq
Novel antibody could help prevent bone, muscle loss due to GLP-1 drugs
February 18, 2025  |  medicalnewstoday.comM
Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug
February 15, 2025  |  aol.comA
Weight-Loss Drugs Like Ozempic Can Help Alcohol Addiction
February 13, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/weight-loss-drugs-like-ozempic-can-help-alcohol-addiction/ar-AA1yVSPd
The 2 sides of Ozempic — weight loss success stories and health nightmares in Kentucky
February 11, 2025  |  wdrb.comW
(OZEM) Investment Analysis
February 1, 2025  |  news.stocktradersdaily.comN
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
January 31, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/about-half-of-americans-approve-of-using-weight-loss-drugs-to-treat-obesity-ap-norc-poll-finds/ar-AA1ybBCG
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
January 30, 2025  |  omaha.comO
Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio
January 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/why-weight-loss-drugs-could-be-game-changers-for-your-investment-portfolio/ar-AA1y909e

Media Sentiment Over Time

Invesco Next Gen Connectivity ETF NYSEARCA:KNCT

$115.86 +0.13 (+0.11%)
As of 02:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Invesco Next Gen Connectivity ETF (KNCT) is an exchange-traded fund that mostly invests in information technology equity. The fund is passively managed, tracking an index comprised of stocks of companies that derive at least 50% of their revenue from future connectivity technologies and products globally. Fund holdings are selected and weighted based on amount of revenue tied to the segment and market capitalization KNCT was launched on Jun 23, 2005 and is issued by Invesco.

KraneShares SSE Star Market 50 Index ETF NYSEARCA:KSTR

$13.68 -0.03 (-0.18%)
As of 02:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The KraneShares SSE STAR Market 50 Index ETF (KSTR) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of the top 50 companies by market-cap that are listed on the Shanghai Stock Exchange (SSE) Science and Technology Innovation Board. KSTR was launched on Jan 27, 2021 and is managed by KraneShares.

First Trust Merger Arbitrage ETF NYSEARCA:MARB

$20.34 -0.22 (-1.05%)
As of 02:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The First Trust Vivaldi Merger Arbitrage ETF (MARB) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively-managed global fund that uses a merger arbitrage strategy to long takeover target and short the acquiring company. MARB was launched on Feb 4, 2020 and is managed by First Trust.

Roundhill GLP-1 & Weight Loss ETF stock logo

Roundhill GLP-1 & Weight Loss ETF NASDAQ:OZEM

$26.10 +0.26 (+1.01%)
As of 01:36 PM Eastern

The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas